The Basics on Cetero Research…
We are Innovative, Dedicated Industry Leaders.
Who Provide Our Clients the Proven Clinical Experience They Need to Meet Their Needs.
At Cetero Research we know our business—and are committed to forward-thinking service. This is how we earned our reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services.
Knowledge and understanding come from experience. Cetero Research offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.
Our mission is simple: To support our partners in the timely completion of research that gets them to the next stage in their clinical development.
How do we achieve this mission?
It starts with a track record of delivery—we have a record of 99% on-time study start-up—that means high client retention and the completion of more than 750 early phase clinical studies each year. Our medical and clinical experts conduct complex studies across a wide range of indications with healthy participants, hard-to-find patients and special populations. Studies that involve study design, protocol development, data management, PK/PD modeling and simulation, and biostatistics.
It is also about dedication—dedication to innovation, acceleration, and superior quality and value.
Finally, it is about our core values—the quality of our services and our dedication to our partners comes from a company-wide focus on integrity, ethics, and teamwork.
Who We Are At a Glance
- Privately-held company based in Cary, North Carolina
- 1,200+ employees and nearly 1,400 beds
- Seven sites throughout North America
- Five clinical pharmacology facilities
- Two bioanalytical laboratories
Read More
